TRAIL诱导的亡和蛋白质体活动 - 机制,信号和相互作用
Chiara Boccellato1, Markus Rehm2
1University of Stuttgart, Institute of Cell Biology and Immunology, Stuttgart 70569, Germany.
Biochimica et biophysica acta. Molecular cell research
|February 18, 2024
概括
这篇评论探讨了如何将TRAIL死亡受体激素和蛋白酶体抑制剂结合起来可以增强癌细胞死亡. 了解这种相互作用对于开发有效的组合癌症疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 编程细胞死亡,包括细胞亡,对于发育,组织平衡和癌症治疗至关重要.
- 准TRAIL (与TNF相关的诱导亡联体) 死亡受体和蛋白酶体抑制剂是已知的抗癌策略.
- TRAIL信号与细胞蛋白质稳定蛋白质的蛋白质体调节之间的相互作用是复杂的,但在治疗上是可利用的.
研究的目的:
- 提供有关 TRAIL 诱导的通路和蛋白酶体活动的详细见解.
- 探索TRAIL和蛋白酶体抑制剂的作用机制和药物可用性.
- 阐明如何利用这些途径之间的相互作用来增强癌细胞的杀死.
主要方法:
- 审查有关TRAIL信号通道的现有文献.
- 分析蛋白质酶的功能及其在细胞蛋白质稳定中的作用.
- 检查涉及TRAIL激动剂和蛋白酶体抑制剂的组合疗法的临床前和临床数据.
主要成果:
- TRAIL介导的亡和蛋白质酶抑制是不同的,但相互关联的细胞过程.
- 当 TRAIL 途径与蛋白酶体抑制剂相结合时,观察到协同效应,导致癌细胞死亡的增强.
- 了解分子交叉声对于优化组合治疗策略至关重要.
结论:
- 针对TRAIL死亡受体和蛋白质酶活性的组合疗法为癌症治疗提供了一个有前途的策略.
- 对复杂的信号网络的进一步研究可以完善治疗方法.
- 本综述提供了全面的概述,以指导新型抗癌治疗的开发.
相关概念视频
01:31The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
01:17The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
01:30Apoptosis
11.4K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.4K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K